Design of core–shell mesoporous silica nanospheres as a delivery system of nimesulide – physicochemical and biological characterization
Abstract
Nimesulide (NMS) is an anti-inflammatory drug, yet its clinical utility is limited by its hydrophobic nature and risk of hepatotoxicity. This study aimed to develop and evaluate the bio-response of core–shell mesoporous silica nanoparticles (MSNs) as carriers to improve the solubility and safety profile of NMS. Three MSN variants were synthesized via a modified sol–gel process by varying reaction times and surfactant concentrations. All materials exhibited a well-defined spherical morphology consisting of a dense silica core and a highly ordered amorphous mesoporous shell. The sample with a shorter reaction time possessed the largest pore diameter, which facilitated the highest NMS loading capacity of 23.5 wt%, compared to 17–18 wt% for the 6 h variants. In vitro biological evaluation using the HepG2 liver cell line confirmed the high biocompatibility of the developed silica carriers, with no significant changes in cell morphology. The results demonstrate that core–shell MSNs are an effective platform for NMS.
© 2026 Sofiia Volosiuk, Sara Wasilewska, Karolina Wenelska, Elżbieta Czarniewska, Dariusz Wawrzyniak, Ewa Mijowska, published by West Pomeranian University of Technology, Szczecin
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.